$1.49
-0.06-3.87%
At close: -
$1.50
0.010.67%
After Hours: Feb 3, 4:48 PM EDT
Comments
Loading...
PharmaCyte Biotech (PMCB) Forecast
NewsEarningsPharmaCyte Biotech (PMCB) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPharmaCyte Biotech (NASDAQ:PMCB) Stock Quotes, Forecast and News Summary
PharmaCyte Biotech Stock (NASDAQ: PMCB) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy PharmaCyte Biotech (PMCB) stock?
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Who are PharmaCyte Biotech (PMCB) competitors?
Other companies in PharmaCyte Biotech’s space includes: Immuron (NASDAQ:IMRN), Acurx Pharmaceuticals (NASDAQ:ACXP), Imunon (NASDAQ:IMNN), Cellectar Biosciences (NASDAQ:CLRB) and Sensei Biotherapeutics (NASDAQ:SNSE).
What is the forecast, or price target, for PharmaCyte Biotech (PMCB) stock?
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
What is the current price for PharmaCyte Biotech (PMCB)?
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $1.5 last updated February 3, 2025 at 4:48 PM EST.
Does PharmaCyte Biotech (PMCB) pay a dividend?
There are no upcoming dividends for PharmaCyte Biotech.
When is PharmaCyte Biotech (NASDAQ:PMCB) reporting earnings?
PharmaCyte Biotech’s Q3 earnings are confirmed for Monday, March 17, 2025.
Is PharmaCyte Biotech (PMCB) going to split?
There is no upcoming split for PharmaCyte Biotech.
What sector and industry does PharmaCyte Biotech (PMCB) operate in?
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.